← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4, two pages.
InvestVerdict

Baroda BNP Paribas Multi Asset Fund

Direct Plan · Growth Option · Multi Asset Allocation · Scheme code 150865

Fund houseBaroda BNP Paribas Mutual Fund
CategoryMulti Asset Allocation
Plan & optionDirect · Growth Option
History3.7 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme 2.733.152.30 13.5916.50 16.36
Nifty 100
benchmark
0.253.49-1.52 1.8410.529.38 12.79
Multi Asset Allocation
category median
10.6816.2914.23 12.25

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fall
This scheme 9.9% 1.01 1.44 0.69 7.25% -11.9% 86.35
Nifty 100
benchmark
17.1%0.23 0.32 -37.0%

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 44 months this scheme and its benchmark share.

Growth of ₹100 since launch

9312215218120242026InvestVerdict

Drawdown from peak (%)

0%-4%-9%-13%20242026

Every one-year period it has lived through

WindowsWorstMedianBestPeriods that lost money
133 1.1% 14.5% 38.3% 0%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

InvestVerdict

Baroda BNP Paribas Multi Asset Fund

Direct Plan · Growth Option

Allocation

By asset

Equity71.48%
Gold13.91%
Debt9.73%
Cash & Equivalents3.80%
REITs / InvITs1.08%

By market cap

Concentration

Number of stocks67
Top 5 stocks26.98%
Top 10 stocks41.00%
Top 20 stocks57.57%
Largest holding7.27%
Largest sectorBanks 14.92%
Effective stocks38.5
Cash3.80%
InvestVerdict

Baroda BNP Paribas Multi Asset Fund

Direct Plan · Growth Option · holdings

Sector split

— 17.6%Banks — 14.9%Electrical Equipment — 5.5%IT - Software — 4.3%Power — 4.1%Petroleum Products — 4.0%Pharmaceuticals & Biotechnology — 3.7%Construction — 3.5%Sovereign — 3.4%Other — 39.1% 17.6%Banks14.9%Electrical Equipment5.5%IT - Software4.3%Power4.1%Petroleum Products4.0%Pharmaceuticals & Biotech…3.7%Construction3.5%Sovereign3.4%Other39.1%
17.58%
Banks14.92%
Electrical Equipment5.46%
IT - Software4.27%
Power4.06%
Petroleum Products4.02%
Pharmaceuticals & Biotechnology3.73%
Construction3.51%
Sovereign3.36%
Food Products3.00%

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 30 Aug 2026.